Fulcrum Pharma
1999
FOUNDED
M&A
STATUS
1-10
EMPLOYEES
Merger of Eq.
LATEST DEAL TYPE
4
FINANCING ROUNDS
1
INVESTMENTS
Description
Provider of drug development support services intended to deliver products faster and more efficiently to the global pharmaceutical market. The company's drug development support services offers assistance to companies in various stages of drug development from research through approval and post-marketing, enabling pharmaceutical and biotechnology companies to achieve drug development and regulatory approval milestones.
Website
Formerly Known As
Protodigm
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Consulting Services (B2B)
Other Industries
Drug Discovery
Acquirer
Former Stock Listing
FUL
Primary Office
- Hemel One Boundary Way
- Hemel Hempstead HP1 1JY
- England, United Kingdom
Fulcrum Pharma Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Fulcrum Pharma‘s full profile, request access.
Request full access to PitchBookFulcrum Pharma Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000 0000000000 | 19-Mar-2007 | 000000000000000000 | 00.000 | Consulting Services (B2B) | 000 00000 |
Fulcrum Pharma Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Fulcrum Pharma‘s full profile, request access.
Request full access to PitchBookFulcrum Pharma Executive Team (2)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Jon Court | Chief Executive Officer |
1 Former Executive
You’re viewing 1 of 2 executives. Get the full list »